Ja. Nagy et al., PATHOGENESIS OF ASCITES TUMOR-GROWTH - VASCULAR-PERMEABILITY FACTOR, VASCULAR HYPERPERMEABILITY, AND ASCITES-FLUID ACCUMULATION, Cancer research, 55(2), 1995, pp. 360-368
Previous studies have shown that accumulation of tumor ascites fluid r
esults in large part from increased permeability of peritoneal lining
vessels (Nagy et at, Cancer Res., 49: 5449-5458, 1989; Nagy et at, Can
cer Res., 53: 2631-2643, 1993). However, the specific microvessels ren
dered hyperpermeable have not been identified nor has the basis of per
itoneal vascular hyperpermeability been established. To address these
questions, TA3/St and MOT carcinomas, web-characterized transplantable
murine tumors that grow in both solid and ascites form, were studied
as model systems. Ascites tumor cells of either type were injected i.p
. into syngeneic A/Jax and C3Heb/FeJ mice, and ascites fluid and plasm
a were collected at intervals thereafter up to 8 and 28 days, respecti
vely. Beginning several days after tumor cell injection, small blood v
essels located in tissues lining the peritoneal cavity (mesentery, per
itoneal wall, and diaphragm) became hyperpermeable to several macromol
ecular tracers (I-125-hunan serum albumin, FITC-dextran, colloidal car
bon, and Monastral Blue B). Increased microvascular permeability corre
lated with the appearance in ascites fluid of vascular permeability fa
ctor (VPF), a tumor cell-secreted mediator that potently enhances vasc
ular permeability to circulating macromolecules. VPF was measured in p
eritoneal fluid by both a functional bioassay and a sensitive immunofl
uorometric assay. The VPF concentration, total peritoneal VPF, ascites
fluid volume, tumor cell number, and hyperpermeability of peritoneal
lining microvessels were found to increase in parallel over time. The
close correlation of peritoneal fluid VPF concentration with the devel
opment of hyperpermeable peritoneal microvessels in these two well-def
ined ascites tumors suggests that VPF secretion by tumor cells is resp
onsible, in whole or in part, for initiating and maintaining the ascit
es pattern of tumor growth.